Condition
Cancer of Pancreas clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Cancer of Pancreas clinical trials that are recruiting, at sites in 5 countries (most in United States (3), United Kingdom (1), Italy (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 5Countries
Newest Cancer of Pancreas clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Registry of images and videos from endoscopic procedures for pancreatic diseases | — | Milan | Recruiting | Apr 3, 2024 |
| Using cell-free DNA to diagnose pancreatic cancer | — | Orlando, Florida | Recruiting | Nov 28, 2023 |
| Evaluating Gemcitabine chemotherapy for metastatic pancreatic cancer patients with the GemCore signature | — | Marseille | Recruiting | Sep 21, 2023 |
| Evaluating tumor types in pancreatic cancer patients receiving FOLFIRINOX treatment | Phase 2 | Chapel Hill, North Carolina | Recruiting | Jun 6, 2019 |
| Identifying tumor molecules for early pancreatic cancer detection | — | Cottingham, Kingston Upon Hull | Recruiting | May 25, 2018 |
| AI-based precision oncology clinical trial matching and registry | — | Birmingham, Alabama and 67 other locations | Recruiting | Mar 2, 2018 |
All recruiting trials (6)
-
Registry of images and videos from endoscopic procedures for pancreatic diseases
This study is collecting images and videos from endoscopic procedures on patients with pancreatic diseases to help improve how these conditions are understood and treated.
-
Using cell-free DNA to diagnose pancreatic cancer
This study is testing whether a new blood test that looks at cell-free DNA can help diagnose pancreatic cancer earlier and more easily than current methods.
-
Evaluating Gemcitabine chemotherapy for metastatic pancreatic cancer patients with the GemCore signature
This study is testing if Gemcitabine chemotherapy can help people with advanced pancreatic cancer who have a specific marker in their tumors.
-
Evaluating tumor types in pancreatic cancer patients receiving FOLFIRINOX treatment
This study is testing how different types of pancreatic cancer respond to the chemotherapy FOLFIRINOX before surgery to see if it helps make the tumors easier to remove.
-
Identifying tumor molecules for early pancreatic cancer detection
This study is trying to find specific molecules in tumors that can help detect pancreatic cancer earlier and more easily for people who might be at risk.
-
AI-based precision oncology clinical trial matching and registry
This study is testing whether an AI tool can help match cancer patients with the right clinical trials based on their specific cancer details to see if it improves their chances of getting into trials and their overall outcomes.
Related topics
Quick answers
How many Cancer of Pancreas clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (3 trials), United Kingdom (1 trial), Italy (1 trial), France (1 trial), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.